Here's a rundown of four technical setups that are showing solid trading potential:
Pfizer Inc. (PFE)
An ascending triangle pattern triggers a buy with a push through $34.60 resistance.
Zimmer Biomet Holdings Inc. (ZBH)
The breakout signal through $120 was confirmed yesterday.
Amgen Inc. (AMGN)
Amgen is still a "buy the dips stock" despite last week's Repatha-driven drop.
Agios Pharmaceuticals Inc. (AGIO)
Its push through $55 yesterday is triggering a long-term rounding bottom buy signal.